Gender Differences of Cardiovascular Disease
- 1 June 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 47 (6) , 1019-1026
- https://doi.org/10.1161/01.hyp.0000223064.62762.0b
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection?Expert Opinion on Investigational Drugs, 2001
- Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-α-Deficient Male MiceBiochemical and Biophysical Research Communications, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Cloning of cDNAs Encoding G Protein-Coupled Receptor Expressed in Human Endothelial Cells Exposed to Fluid Shear StressBiochemical and Biophysical Research Communications, 1997
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Cloning of a Novel Member of the G Protein-Coupled Receptor Family Related to Peptide ReceptorsBiochemical and Biophysical Research Communications, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986